Apella

About Apella

Apella is a real-time operating room (OR) optimization platform powered by ambient AI and integrated with electronic health records (EHR). It provides surgical teams with ground-truth data to serve more patients efficiently, prevent delays, and improve care quality while reducing staff burnout.

Products & Services

Apella Platform:A real-time OR optimization platform that uses AI and EHR integration to streamline surgical schedules, prevent delays, improve turnovers, coordinate teams, track performance, and optimize capacity.

Apella Horizon:A new product introduced to optimize schedules and maximize OR capacity using AI and real-time data.

Specialties

Ambient AI Computer Vision Operating Room Optimization Real-time Data Analytics EHR Integration

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 80000000 MR: - FA: $80 million FAN: 80000000	D: 2026-01-08 FD: 2026-01-08	9 investors

Series B Latest

2026-01-08

$80.0M

9 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Roberta Schwartz

Chief Innovation Officer

R

Radhika Charlap

Director of Product Marketing

LinkedIn (Pro only)

K

Kate Lipman

Marketing Specialist

LinkedIn (Pro only)

R

Ryan Goldman

Vice President of Marketing

View 1 more team members with Pro

Unlock Full Team Directory

Recent News

Apella Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised